President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug